Evaluation of EverLift in the Performance of Polypectomy for Polyps 4-9mm

NACompletedINTERVENTIONAL
Enrollment

158

Participants

Timeline

Start Date

September 16, 2020

Primary Completion Date

May 31, 2021

Study Completion Date

July 15, 2021

Conditions
Colo-rectal CancerPolyp of ColonAdenomatous Polyp of Colon
Interventions
DEVICE

Use of EverLift

Use of EverLift for submucosal injection prior to polypectomy

DEVICE

Without use of EverLift

Without use of EverLift for submucosal injection prior to polypectomy

Trial Locations (1)

94304

Veterans Affairs Palo Alto Health Care System, Palo Alto

All Listed Sponsors
lead

Stanford University

OTHER

NCT04551014 - Evaluation of EverLift in the Performance of Polypectomy for Polyps 4-9mm | Biotech Hunter | Biotech Hunter